John W. Creecy

BiOptix Diagnostics, Inc. develops biosensor for detection of bacteria and viruses. Its product 404pi offers scientists that require label-free, real-time detection of bio-molecular interactions an extremely high sensitivity, low noise instrument. The company was founded by Misha Plam, Slava Petropavlovskikh and Oyvind Nilsen in 2003 and is headquartered in Boulder, CO.

BiOptix Diagnostics, Inc. develops biosensor for detection of bacteria and viruses. Its product 404pi offers scientists that require label-free, real-time detection of bio-molecular interactions an extremely high sensitivity, low noise instrument. The company was founded by Misha Plam, Slava Petropavlovskikh and Oyvind Nilsen in 2003 and is headquartered in Boulder, CO.

VuCOMP, Inc. designs and develops computer aided detection systems for mammography. It offers M-Vu system, a medical device that screens mammogram images for abnormalities such as masses, architectural distortions, and calcifications. The company was founded by James Pike in 2001 and is headquartered in Plano, TX.

Remeditex Ventures LLC (Remeditex Ventures) is a venture capital firm founded in 2011. The firm is headquartered in Dallas, Texas.

BiO2 Medical, Inc. engages in the design, development, and manufacturing of clinical products. The company was founded by Luis F. Angel, Christopher E. Banas, and Paul Castella in December 2006 and is headquartered in Golden, CO.

BiO2 Medical, Inc. engages in the design, development, and manufacturing of clinical products. The company was founded by Luis F. Angel, Christopher E. Banas, and Paul Castella in December 2006 and is headquartered in Golden, CO.

BiOptix Diagnostics, Inc. develops biosensor for detection of bacteria and viruses. Its product 404pi offers scientists that require label-free, real-time detection of bio-molecular interactions an extremely high sensitivity, low noise instrument. The company was founded by Misha Plam, Slava Petropavlovskikh and Oyvind Nilsen in 2003 and is headquartered in Boulder, CO.

Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA.

Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA.

BiOptix Diagnostics, Inc. develops biosensor for detection of bacteria and viruses. Its product 404pi offers scientists that require label-free, real-time detection of bio-molecular interactions an extremely high sensitivity, low noise instrument. The company was founded by Misha Plam, Slava Petropavlovskikh and Oyvind Nilsen in 2003 and is headquartered in Boulder, CO.

Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA.

BiO2 Medical, Inc. engages in the design, development, and manufacturing of clinical products. The company was founded by Luis F. Angel, Christopher E. Banas, and Paul Castella in December 2006 and is headquartered in Golden, CO.

Remeditex Ventures LLC (Remeditex Ventures) is a venture capital firm founded in 2011. The firm is headquartered in Dallas, Texas.

Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA.

Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA.

Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA.

Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA.

Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA.

Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA.

Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA.

VuCOMP, Inc. designs and develops computer aided detection systems for mammography. It offers M-Vu system, a medical device that screens mammogram images for abnormalities such as masses, architectural distortions, and calcifications. The company was founded by James Pike in 2001 and is headquartered in Plano, TX.

BiOptix Diagnostics, Inc. develops biosensor for detection of bacteria and viruses. Its product 404pi offers scientists that require label-free, real-time detection of bio-molecular interactions an extremely high sensitivity, low noise instrument. The company was founded by Misha Plam, Slava Petropavlovskikh and Oyvind Nilsen in 2003 and is headquartered in Boulder, CO.

BiOptix Diagnostics, Inc. develops biosensor for detection of bacteria and viruses. Its product 404pi offers scientists that require label-free, real-time detection of bio-molecular interactions an extremely high sensitivity, low noise instrument. The company was founded by Misha Plam, Slava Petropavlovskikh and Oyvind Nilsen in 2003 and is headquartered in Boulder, CO.

BiO2 Medical, Inc. engages in the design, development, and manufacturing of clinical products. The company was founded by Luis F. Angel, Christopher E. Banas, and Paul Castella in December 2006 and is headquartered in Golden, CO.

BiOptix Diagnostics, Inc. develops biosensor for detection of bacteria and viruses. Its product 404pi offers scientists that require label-free, real-time detection of bio-molecular interactions an extremely high sensitivity, low noise instrument. The company was founded by Misha Plam, Slava Petropavlovskikh and Oyvind Nilsen in 2003 and is headquartered in Boulder, CO.

Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA.

BiO2 Medical, Inc. engages in the design, development, and manufacturing of clinical products. The company was founded by Luis F. Angel, Christopher E. Banas, and Paul Castella in December 2006 and is headquartered in Golden, CO.

Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA.

BiOptix Diagnostics, Inc. develops biosensor for detection of bacteria and viruses. Its product 404pi offers scientists that require label-free, real-time detection of bio-molecular interactions an extremely high sensitivity, low noise instrument. The company was founded by Misha Plam, Slava Petropavlovskikh and Oyvind Nilsen in 2003 and is headquartered in Boulder, CO.

BiOptix Diagnostics, Inc. develops biosensor for detection of bacteria and viruses. Its product 404pi offers scientists that require label-free, real-time detection of bio-molecular interactions an extremely high sensitivity, low noise instrument. The company was founded by Misha Plam, Slava Petropavlovskikh and Oyvind Nilsen in 2003 and is headquartered in Boulder, CO.

Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA.

Remeditex Ventures LLC (Remeditex Ventures) is a venture capital firm founded in 2011. The firm is headquartered in Dallas, Texas.

BiOptix Diagnostics, Inc. develops biosensor for detection of bacteria and viruses. Its product 404pi offers scientists that require label-free, real-time detection of bio-molecular interactions an extremely high sensitivity, low noise instrument. The company was founded by Misha Plam, Slava Petropavlovskikh and Oyvind Nilsen in 2003 and is headquartered in Boulder, CO.

Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA.

Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA.

Remeditex Ventures LLC (Remeditex Ventures) is a venture capital firm founded in 2011. The firm is headquartered in Dallas, Texas.